Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$47.19 - $62.68 $10.9 Million - $14.4 Million
-230,000 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$56.91 - $67.81 $3.76 Million - $4.48 Million
-66,000 Reduced 22.3%
230,000 $13.8 Million
Q2 2021

Aug 16, 2021

SELL
$64.02 - $71.72 $6.66 Million - $7.46 Million
-104,000 Reduced 26.0%
296,000 $20.1 Million
Q1 2021

May 17, 2021

SELL
$53.26 - $68.08 $7.46 Million - $9.53 Million
-140,000 Reduced 25.93%
400,000 $26.2 Million
Q4 2020

Feb 16, 2021

BUY
$43.41 - $56.51 $3.91 Million - $5.09 Million
90,000 Added 20.0%
540,000 $30.4 Million
Q3 2020

Nov 16, 2020

BUY
$47.43 - $60.75 $21.3 Million - $27.3 Million
450,000 New
450,000 $21.9 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.